23 June 2015
The Lancet article, Prescribing safety: ensuring that new graduates are prepared (published on 13 February 2015) received several responses from international readers. The submitted correspondence can be viewed below:
22 June 2015
The British Pharmacological Society and Queen Mary University of London (QMUL) are pleased to announce that the next Editor-in-Chief of the British Journal of Pharmacology will be Professor Amrita Ahluwalia, Deputy Director of QMUL’s William Harvey Research Institute.
09 June 2015
The Society's hosted event 'Are we over-medicated?' presented by Professor Simon Maxwell, Dr Jacintha Sivarajah and Dr Angela Coulter received widespread coverage in the weekend's national newspapers. The event highlighted the issue of polypharmacy and discussed how we might address this in the future including through patients being better informed about their healthcare choices. Find out more about where to find reliable information about treatment options.
09 June 2015
It is with great pleasure that the British Pharmacological Society announces the winners of the Society’s most recently-judged prizes and awards. These prizes will be officially awarded as part of the Society’s flagship meeting Pharmacology 2015, at the Annual Dinner and Prize-Giving.
26 May 2015
BJCP press release
Six-times higher risk in Ireland and a two-fold higher risk in the UK highlighted in study
A fifty-fold between-country difference in rates of paracetamol-induced acute liver failure that leads to liver transplant (ALFT) has been revealed by a study that compared patient data from seven countries at the request of the European Medicines Agency: France, Greece, Ireland, Italy, Netherlands, Portugal and the UK. Researchers discovered that this variation was even more pronounced on a per-capita basis, with a 200-fold difference in ALFT cases. Publishing these findings in the British Journal of Clinical Pharmacology, the authors call for further research to identify the underlying causes.
19 May 2015
Dr Ben Whalley, professor of neuropharmacology at the University of Reading contributes to Financial Times article (subscription required) ‘High hopes for ‘first cannabis pharmacy’. Dr Whalley cast doubt on the pharmacy’s (Carun) claims about the health effects of its products, saying they had not been proved in “valid human clinical trials”.
18 May 2015
It was with great pleasure that we saw the Society of Biology’s news regarding its new royal title. The British Pharmacological Society congratulates the Society of Biology and Dr Mark Downs for this well-deserved recognition.
28 April 2015
A series of networking workshops for researchers
London (25 June), Dundee (3 July), Nottingham (7 July)
The Learned Society Partnership on Antimicrobial Resistance (AMR) is holding three interdisciplinary networking workshops to bring together researchers, from all career stages, who have an interest in fundamental or translational research relating to the evolution and transmission of AMR.
25 March 2015
An editorial in April's edition of the British Journal of Clinical Pharmacology describing how the drug TAB08 is being tested for use in treating rheumatoid arthritis has been covered by Reuters. The drug received extensive news coverage in 2006 when it caused dramatic side-effects in a clinical trial nine years ago at Northwick Park.
Since then, Profess David Webb, President Elect of the British Pharmacological Society, has explained the value of volunteers in clinical trials and the impact of improved safety measures in the UK since the 2006 Northwick Park clinical trial.
13 March 2015
Studies published in BJCP have been used in a report, published by the Australian National Health and Medical Research Council, that concludes, there is no good quality evidence to support the claim that homeopathy is effective in treating any health conditions. The three BJCP studies referenced by the Australian report were: